Global Urethral Bulking System Market Opportunities and Forecast 2023-2030

Urethral Bulking System Market Overview

The global Urethral Bulking System market is projected to witness significant growth in the forecast period. Increasing incidences of urinary continence among females is a key factor that is estimated to boost the global ureteral bulking system market during the forecast period.  According to the National Center for Biotechnology Information, it is estimated that the number of women in the United States with urinary incontinence will rise from 18.3 million in 2010 to 28.4 million in 2050. Additionally, pregnancy, childbirth, hysterectomy, menopause are some of the major physical stages that lead to urethral incontinence among women. Also, changing lifestyle is the key factor leading to urethral incontinence. All these important factors ultimately raise the growth of the Urethral Bulking System market.

Moreover, increasing awareness about urinary incontinence and the availability of ureteral bulking system kits to manage the condition is projected to enlarge the market in the next few years. Furthermore, the availability of various bulking agents offered by key players and strong distribution channels offering bulking agents are expected to propel the growth of the global Urethral Bulking System market in the coming years.

On the downside, fewer side-effects related to the patients using ureteral bulking agents, such as transient urinary retention, hematuria, bulking agent extrusion, and granuloma formation, are projected to hamper the growth of the ureteral bulking system market during the forecast period. 

Covid-19 Impact on Urethral Bulking System Market:

In addition, the current Urethral Bulking System Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Urethral Bulking System Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Urethral Bulking System Market Segment Overview

Based on the disease type, the Stress urinary incontinence segment has the largest share in the market.  Urethral bulking agents are the best alternative to surgical intervention in women with stress urinary incontinence. In addition to this, the ureteral bulking system is a kit containing innovative gel, that provides clinical effectiveness and durability that is projected to offer low treatment morbidity and low risk of adverse actions. This important factor remarkably contributes to the growth of the global Urethral Bulking System market in the forthcoming period.

Urethral Bulking System Market, By Disease Type

·       Stress urinary incontinence
·       Urge incontinence
·       Overflow incontinence
·       Functional incontinence
·       Others

Urethral Bulking System Market, By Agent

·       Bulkamid
·       Coaptite
·       Durasphere
·       Macroplastique
·       Others

Urethral Bulking System Market, By End-User

·       Hospitals
·       Clinics
·       Ambulatory Surgical Centers
·       Others

Urethral Bulking System Regional Overview

Region-wise, North America is projected to account for the largest share of the global Urethral Bulking System market. This can be attributed to the rising prevalence of urinary incontinence among adults, the availability of innovative bulking gel, and the presence of key players offering urethral bulking system kits are projected to boost the growth of the market in this region. In addition to this, increasing the adoption of macroplastique bulking agents for the treatment of stress urinary incontinence in men and women is further propelling the growth of the market in this region. Likewise, Asia Pacific is expected to emerge as a significant region in the Urethral Bulking System market. Increasing incidence of stress urinary incontinence in the region in both men and women is the main factor that is expected to boost the market in this region. According to NCBI research, the incidence rate of stress urinary incontinence in women in China is projected to be 12.9%, as compared to other types of urinary incontinence.

Urethral Bulking System Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Urethral Bulking System Market Competitor overview

Some key developments and strategies adopted by manufacturers in Urethral Bulking System are highlighted below.

·       In June 2021, Axonics, Inc., a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, has filed a premarket approval (PMA) supplement with the FDA for its newly developed, long-lived, non-rechargeable sacral neuromodulation (SNM) implantable neurostimulator (INS).

Urethral Bulking System Market, Key Players

·       Boston Scientific Corporation or its affiliates
·       Contura Ltd.
·       Coloplast Corp
·       CR Bard
·       Merz Aesthetics
·       Cogentix Medical
·       Uroplasty, Inc.
·       Q-Med
·       ASCENTX MEDICAL, INC.
·       AstraZeneca